Matthew G Annis

7PUBLICATIONS
56CO-AUTHORS
Metabolic medicineMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 06, 2024
Mitochondrial elongation impairs breast cancer metastasis.

Lucía Minarrieta, Matthew G Annis, Yannick Audet-Delage

|Jun 21, 2024
Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver Metastasis.

Sébastien Tabariès, Alma Robert, Anne Marcil

|Jan 17, 2024
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer.

Regina Cencic, Young K Im, Sai Kiran Naineni

|Jun 03, 2021
Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.

Sébastien Tabariès, Matthew G Annis, Anthoula Lazaris

Pageof 2